Therapeutic goal attainment in patients with hypertension and dyslipidemia.
作者： Michael L. Johnson , Kenneth Pietz , David S. Battleman , Rebecca J. Beyth
DOI: 10.1097/01.MLR.0000188982.25397.37
关键词: In patient 、 Physical therapy 、 Dyslipidemia 、 Therapeutic goal 、 Intensive care medicine 、 Disease 、 Multiple risk factors 、 Concomitant 、 Medicine
摘要: Background:Recent guidelines emphasize the need to assess and treat overall risk for cardiovascular disease through concomitant management of multiple factors. We sought ascertain treatment patterns attainment therapeutic goals in patients with isolated hypertensio
sci-hub.se 参考文章(34)
Leona Markson, Marc L Berger, Soma Nag, Charles M Alexander, J D Lu, Andrew Mosso, Sally Wade, Robert W Dubois, Growth in use of lipid-lowering therapies: are we targeting the right patients? The American Journal of Managed Care. ,vol. 8, pp. 862- ,(2002)
, Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials The Lancet. ,vol. 362, pp. 1527- 1535 ,(2003) , 10.1016/S0140-6736(03)14739-3
Jerry H. Gurwitz, Sumit R. Majumdar, Terry S. Field, George W. Reed, Susan E. Andrade, Robert Black, Michael Kelleher, Hypertension management: the care gap between clinical guidelines and clinical practice The American Journal of Managed Care. ,vol. 10, pp. 481- 486 ,(2004)
A Zanchetti, R Cifkova, S Erdine, G McInnes, M Safar, JL Rodicio, P van Zwieten, EO Brien, EA Rosei, Jan A Staessen, F Zannad, S Kjeldsen, JM Mallion, KH Rahn, B Waeber, B Williams, K Kawecka-Jaszcs, AM Heagerty, G DeBacker, Robert Fagard, G Mancia, SG Priori, W Kiowski, LM Ruilope, T Luscher, C Farsang, NR Poulter, 2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension web science. ,vol. 21, pp. 1011- 1053 ,(2003) , 10.1097/01.HJH.0000059051.65882.32
Michael Pignone, Christopher Phillips, Cynthia Mulrow, Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials BMJ. ,vol. 321, pp. 983- 986 ,(2000) , 10.1136/BMJ.321.7267.983
Mark Monane, Rhonda L Bohn, Jerry H Gurwitz, Robert J Glynn, Raisa Levin, Jerry Avorn, The Effects of Initial Drug Choice and Comorbidity on Antihypertensive Therapy Compliance Results From a Population-Based Study in the Elderly American Journal of Hypertension. ,vol. 10, pp. 697- 704 ,(1997) , 10.1016/S0895-7061(97)00056-3
Earl S Ford, Ali H Mokdad, Wayne H Giles, George A Mensah, None, Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation. ,vol. 107, pp. 2185- 2189 ,(2003) , 10.1161/01.CIR.0000066320.27195.B4
F Thomas, K Bean, L Guize, S Quentzel, P Argyriadis, A Benetos, Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women. European Heart Journal. ,vol. 23, pp. 528- 535 ,(2002) , 10.1053/EUHJ.2001.2888
David A Wood, Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries The Lancet. ,vol. 357, pp. 995- 1001 ,(2001) , 10.1016/S0140-6736(00)04235-5
Nathan D Wong, Jose R Pio, Stanley S Franklin, Gil J L’Italien, Tripthi V Kamath, G.Rhys Williams, Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome. American Journal of Cardiology. ,vol. 91, pp. 1421- 1426 ,(2003) , 10.1016/S0002-9149(03)00392-8